Skip to main content
HOUSE 3024118th CongressReferred to the Committee on Education and the Workforce, and in addition to the Committees on Oversight and Accountability, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Life Saving Leave Act

Last Action
4/28/2023

Actions

  • 2023-04-28Referred to the Committee on Education and the Workforce, and in addition to the Committees on Oversight and Accountability, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-04-28Referred to the Committee on Education and the Workforce, and in addition to the Committees on Oversight and Accountability, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-04-28Referred to the Committee on Education and the Workforce, and in addition to the Committees on Oversight and Accountability, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-04-28Introduced in House
  • 2023-04-28Introduced in House

CRS Summary

As of 2023-04-28 (00)

Life Saving Leave Act

This bill expands employee medical leave to provide additional time for bone marrow or blood stem cell donations.

Specifically, the bill expands leave under the Family and Medical Leave Act of 1993 (FMLA) to provide up to 40 hours of leave every 12 months for related predonation, donation, and postdonation activities. Under the bill, leave may be taken intermittently or on a reduced leave schedule. An employee has the option to substitute accrued paid vacation, personal, or sick leave for the unpaid FMLA time.

The bill requires an employee to make a reasonable effort to schedule treatments for when the treatment would not unduly disrupt the employer's activities.

Eligible employees may use this leave regardless of the employee's length of employment or the size of the employer.

Cosponsors (20)

  • Brian Fitzpatrick (R-PA)
  • Doris Matsui (D-CA)
  • Jasmine Crockett (D-TX)
  • CHRISTOPHER SMITH (R-NJ)
  • Joe Neguse (D-CO)
  • Yadira Caraveo (D-CO)
  • Mark DeSaulnier (D-CA)
  • Josh Gottheimer (D-NJ)
  • Steve Cohen (D-TN)
  • Michael Lawler (R-NY)
  • Mary Peltola (D-AK)
  • Brad Finstad (R-MN)
  • Eric Sorensen (D-IL)
  • Andy Kim (D-NJ)
  • Greg Landsman (D-OH)
  • Sharice Davids (D-KS)
  • Salud Carbajal (D-CA)
  • Jimmy Panetta (D-CA)
  • Mark Pocan (D-WI)
  • Seth Magaziner (D-RI)
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.